Jamieson, Dara G, MD PC

Jamieson, Dara G, MD PC, a for-profit subchapter S corporation and sole proprietor medical practice based in New York, provides medical case review and expert witness services for federal vaccine injury compensation proceedings as a prime contractor under blanket purchase agreements with the Department of Health and Human Services. The practice operates predominantly under total small business set-asides on individual task orders, though the parent IDV carries no set-aside designation at the BPA level.

The vendor's federal footprint is concentrated almost entirely within HHS's Health Resources and Services Administration Headquarters, which accounts for 252 of 254 awards and the full $9.6 million in combined potential value. A single Department of Justice expert witness engagement in the U.S. Attorney's Offices (valued at $5 thousand) and one unawardable or unexercised civil-division task represent the remaining activity. Jamieson, Dara G, MD PC serves as the evaluating physician for vaccine injury claims filed under the National Vaccine Injury Compensation Program (VICP), a no-fault federal compensation program. The medical expert services include case review, analysis of medical records, preparation of expert medical opinions, and expert testimony to support claim adjudication. Work is performed exclusively in New York, New York.

The vendor holds three active BPAs with HRSA Headquarters, the largest valued at $7.5 million through November 2027 (contract HSB114 C 7172, awarded November 2022), a second at $249,999 through May 2026, and a third carrying a smaller ceiling. The largest BPA has issued 127 task orders with $1.2 million in combined potential value since award. Individual task order ceilings range from $375 to $37,500, with most calls valued between $1,500 and $24,375. Recent task orders illustrate the work: a $99,375 ceiling call awarded September 1, 2026 for medical case review services, a $75,000 call from August 25, 2026, and a $37,500 call from August 4, 2026 — all under HSB114 C 7172.

Activity was heaviest in 2023 (61 awards) and 2022 (45 awards), declining to 39 in 2024, 9 in 2025, and 10 through September 2026. Ten awards with ultimate completion dates in the next twenty-four months carry $383 thousand in combined potential value and face recompete or renewal. The vendor's category concentration reflects its narrow focus: 128 awards fall under NAICS 541611 (Administrative Management and General Management Consulting Services), 125 under NAICS 621111 (Offices of Physicians except Mental Health Specialists), and all 254 awards carry PSC code Y3 (Support—Professional: Expert Witness). The $1.6 million in obligated dollars across all awards represents 17 percent of combined potential value, indicating significant task orders remain unexercised or incomplete.